• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA grants full approval to AbbVie's ovarian cancer therapy

cafead

Administrator
Staff member
  • cafead   Mar 24, 2024 at 10:32: PM
via The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie's (ABBV.N) "guided missile" cancer therapy, Elahere, for patients with a type of ovarian cancer.

article source
 

<